Viewing StudyNCT00095927



Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00095927
Status: COMPLETED
Last Update Posted: 2017-01-04
First Post: 2004-11-09

Brief Title: Randomized Amifostine For SCCHN
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Xerostomia
Chemotherapeutic Agent Toxicity
Head and Neck Cancer
Mucositis
Radiation Toxicity
Keywords:
Name View
metastatic squamous neck cancer with occult primary squamous cell carcinoma View
radiation toxicity View
chemotherapeutic agent toxicity View
mucositis View
xerostomia View
stage II squamous cell carcinoma of the lip and oral cavity View
stage III squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
stage II squamous cell carcinoma of the oropharynx View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
stage II squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
stage II squamous cell carcinoma of the larynx View
stage III squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
stage II squamous cell carcinoma of the paranasal sinus and nasal cavity View
stage III squamous cell carcinoma of the paranasal sinus and nasal cavity View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
untreated metastatic squamous neck cancer with occult primary View